Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

Holly Hagan; Mary H. Latka; Jennifer V. Campbell; Elizabeth T. Golub; Richard S. Garfein; David A. Thomas; Farzana Kapadia; Steffanie A. Strathdee

doi:10.1086/499951

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

Holly Hagan, Mary H. Latka, Jennifer V. Campbell, Elizabeth T. Golub, Richard S. Garfein, David A. Thomas, Farzana Kapadia, Steffanie A. Strathdee

Research output: Contribution to journal › Article › peer-review

Abstract

Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

Original language	English (US)
Pages (from-to)	669-672
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	42
Issue number	5
DOIs	https://doi.org/10.1086/499951
State	Published - Mar 1 2006

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/499951

Cite this

@article{d833a734dcae42fdbeb5606de6b76a5a,

title = "Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities",

abstract = "Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.",

author = "Holly Hagan and Latka, {Mary H.} and Campbell, {Jennifer V.} and Golub, {Elizabeth T.} and Garfein, {Richard S.} and Thomas, {David A.} and Farzana Kapadia and Strathdee, {Steffanie A.}",

year = "2006",

month = mar,

day = "1",

doi = "10.1086/499951",

language = "English (US)",

volume = "42",

pages = "669--672",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

AU - Hagan, Holly

AU - Latka, Mary H.

AU - Campbell, Jennifer V.

AU - Golub, Elizabeth T.

AU - Garfein, Richard S.

AU - Thomas, David A.

AU - Kapadia, Farzana

AU - Strathdee, Steffanie A.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

AB - Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

UR - http://www.scopus.com/inward/record.url?scp=33144471501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33144471501&partnerID=8YFLogxK

U2 - 10.1086/499951

DO - 10.1086/499951

M3 - Article

C2 - 16447112

AN - SCOPUS:33144471501

SN - 1058-4838

VL - 42

SP - 669

EP - 672

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 5

ER -

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this